Page last updated: 2024-08-24

adenosine and Heart Failure

adenosine has been researched along with Heart Failure in 112 studies

Research

Studies (112)

TimeframeStudies, this research(%)All Research%
pre-19907 (6.25)18.7374
1990's20 (17.86)18.2507
2000's36 (32.14)29.6817
2010's38 (33.93)24.3611
2020's11 (9.82)2.80

Authors

AuthorsStudies
Bisignani, A; Crea, F; DE Vita, A; Denora, M; Filice, M; Golino, M; Ingrasciotta, G; Lamendola, P; Lanza, GA; Lanza, O; Manfredonia, L; Ravenna, SE; Ruscio, E; Villano, A1
Kruyt, ND; Nossent, AY; Quax, PHA; Woudenberg, T1
Devaux, Y; Dong, X; Jäger, C; Leszek, P; Linster, CL; Lumley, AI; Mączewski, M; Niedolistek, M; Oknińska, M; Paterek, A; Vausort, M1
Braun, T; Dieterich, C; Garcia-Gonzalez, C; Graumann, J; Kubin, T; Li, X; Maroli, G; Schneider, A; Stellos, K; Wiesnet, M; Wietelmann, A; Yuan, X1
Alfredsson, J; Ekenbäck, C; Erlinge, D; Hagström, H; Hambreus, K; Henareh, L; James, S; Omerovic, E; Redfors, B; Venetsanos, D1
Aurigemma, C; Bianchini, E; Burzotta, F; Ciliberti, G; Crea, F; D'Amario, D; Galli, M; Laborante, R; Leone, AM; Montone, RA; Princi, G; Restivo, A; Rodolico, D; Romagnoli, E; Trani, C; Vergallo, R; Zito, A1
Alcedo, KP; Battaglia, RA; Minor, M; Snider, NT1
Baine, S; Bonilla, IM; Carnes, CA; Fedorov, VV; Glynn, P; Györke, S; Hund, TJ; Kumar, S; Lee, NY; Long, VP; Mohler, PJ; Mowrey, K; Schober, K; Weiss, R1
Cheng, L; Eilbert, W1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Accornero, F; Dorn, LE; He, C; Hinger, SA; Janssen, PML; Wei, J; Whitson, BA1
Gao, X; Wu, Y; Xu, Y; Zhan, S1
Arnold, JR; Gulsin, GS; Khoo, J; Lai, FY; Levelt, E; McCann, GP; Shetye, A; Squire, IB; Swarbrick, DJ1
Alter, C; Borg, N; Ding, Z; Quast, C; Schrader, J1
Arnold, JR; Cheng, ASH; Kanagala, P; Marsh, AM; McAdam, J; McCann, GP; Ng, LL; Singh, A; Squire, IB1
Asanuma, H; Kitakaze, M1
Adatia, I; Atkins, DL; Checchia, PA; DeCaen, A; Fink, EL; Hazinski, MF; Hoffman, GM; Jefferies, JL; Kleinman, M; Krawczeski, CD; Laussen, PC; Licht, DJ; MacLaren, G; Macrae, D; Marino, BS; Ravishankar, C; Samson, RA; Tabbutt, S; Thiagarajan, RR; Toms, R; Tweddell, J1
Bonello, L; Cautella, J; Colomb, B; Cordier, C; Fenouillet, E; Gaubert, M; Guieu, R; Kerbaul, F; Kipson, N; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Resseguier, N; Ruf, J; Thuny, F1
Adamiak, M; Agarwal, N; Bouchareb, R; Chen, J; Chepurko, E; Fish, K; Hajjar, RJ; Ishikawa, K; Jha, D; Kohlbrenner, E; Lebeche, D; Liang, Y; Mathiyalagan, P; Mayourian, J; Sahoo, S; Sassi, Y; Singh, R; Trivieri, MG; Zhang, S1
Carreras, F; Díaz-Villanueva, J; Estofán, M; Gómez-Revelles, S; López-Lima, I; Pons-Lladó, G; Pujadas, S; Rossello, X; Sciarresi, E1
Baran, DA; Carter, KT; Cochran, RP; Copeland, H; Copeland, JG; Creswell, LL; Lirette, ST; Panos, AL1
Burzotta, F; Corvo, P; Cosentino, N; Crea, F; D'Amario, D; De Caterina, AR; De Vita, MR; Fabbiocchi, F; Ferrari, R; La Torre, G; Leone, AM; Lo Schiavo, P; Niccoli, G; Olivares, P; Porto, I; Rigattieri, S; Romagnoli, E; Tarantino, F; Tomai, F; Trani, C; Valgimigli, M1
Gupta, RC; Kohli, S; Lanfear, DE; Rastogi, S; Sabbah, HN; Wang, M; Zhang, K1
Camici, PG; Colombo, A; Durante, A; Latib, A; Pizzetti, G1
Biesiadecki, BJ; Billman, GE; Carnes, CA; Csepe, TA; Fedorenko, O; Fedorov, VV; Glukhov, AV; Györke, S; Hage, LT; Hansen, BJ; Kalyanasundaram, A; Li, N; Lou, Q; Mohler, PJ; Weiss, R1
Maggioni, AP1
Bryant, SM; Dudley, DJ; Halestrap, AP; James, AF; Khaliulin, I; Suleiman, MS1
Brennan, S; Hudman, D; Jackson, R; Lodwick, D; Norman, RI; Patel, M; Rainbow, RD; Sims, MW1
Fukushima, Y; Hakozaki, K; Hashimoto, H; Ishihara, K; Kiriyama, T; Kobayashi, Y; Kumita, S; Sakurai, M; Shimizu, W; Suda, M; Takahashi, N; Takano, H; Tomiyama, T1
Al-Kindi, SG; Benatti, RD; Deo, S; ElAmm, C; Ginwalla, M; Medalion, B; Oliveira, GH; Osman, MN; Park, SJ; Qattan, MY; Simon, DI1
Dilsizian, V; Gottdiener, J; Gottlieb, SS; Harris, KM; Kop, W; Krantz, DS; Li, S; Rodriguez, GA; Shankovich, A; Smith, MF; Wawrzyniak, AJ; Whittaker, KS1
Albrecht-Küpper, B; Dinh, W; Gheorghiade, M; Sabbah, HN; van der Laan, M; Voors, AA1
Asakura, M; Asanuma, H; Fujita, M; Funaya, H; Furukawa, H; Hori, M; Isomura, T; Kitakaze, M; Komamura, K; Nakamaru, K; Sanada, S; Sawa, Y; Taketani, S; Tsukamoto, O1
By, Y; Condo, J; Deharo, JC; Franceschi, F; Giorgi, R; Guieu, R; Ibrahim, Z; Monserrat, C; Saadjian, A1
Dubois, C1
Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M1
Davies, RA; Haddad, H; Mielniczuk, L; Reinglas, J1
Boccanelli, A; Brandimarte, C; Brandimarte, F; Cacciatore, G; Fedele, F; Gheorghiade, M; Mureddu, GF1
Devaux, Y; Wagner, DR1
Liang, S; Lin, H; Mo, A; Wen, Z; Zhang, F; Zhou, Y1
Hocher, B1
Bhatta, L; Ford, T; Kozman, H; Kshatriya, S; Liu, K; Michiel, R; Salah, A; Siddiqui, D; Villarreal, D1
Hullin, R; Keller, RF; Lerch, R; Meyer, P; White, M1
Floras, JS; Parmar, G; Rongen, GA; Wijeysundera, HC1
Bettari, L; Bugatti, S; Carubelli, V; Dei Cas, L; Lazzarini, V; Lombardi, C; Metra, M1
Arnaoutakis, GJ; Baumgartner, WA; Conte, JV; George, TJ; Shah, AS1
Andreotti, F; Buffon, A; Castriota, F; Cremonesi, A; Gurbel, PA; Kozinski, M; Kubica, A; Kubica, J; Musumeci, G; Navarese, EP; Tavazzi, L1
Arnaoutakis, GJ; Beaty, CA; Conte, JV; George, TJ; Halushka, MK; Shah, AS1
Gongadze, NV; Sukoyan, GV1
Niccoli, G; Sgueglia, GA; Tarantini, G1
Arora, R; Khosla, K; Khosla, S; Molnar, J; Shah, T; Singh, M; Singh, P1
Anderson, RD; Azarbal, B; Handberg, E; Johnson, BD; Kar, S; Kelsey, SF; Kothawade, K; Lerman, A; Mehta, PK; Merz, CN; Pepine, CJ; Petersen, J; Samuels, B; Sharaf, B; Shaw, L; Shufelt, C; Sopko, G; Wei, J1
Miller, JM; Williams, ES1
Ostrovskiĭ, IuP; Sidorenko, GI1
Chan, KY; Chiu, CW; Lam, WW; Sanderson, JE; So, NM1
Ali, S; Gouin, S1
Modlinger, PS; Welch, WJ1
DAL SANTO, G; GALEONE, A1
Birks, EJ; Johnson, PH; Kaletha, K; Kalsi, KK; Rybakowska, IM; Slominska, E; Smolenski, RT; Yacoub, MH; Yuen, AH1
Sharma, M; Teerlink, JR1
Tsubakihara, Y1
Abbracchio, MP; Camurri, A; Capecchi, PL; Diciolla, F; Laghi-Pasini, F; Lazzerini, PE; Maccherini, M; Mazzola, A; Pompella, G1
Alexander, RW; Gibbons, RJ; Kloner, RA; Ross, AM; Stone, GW1
Boscoe, M; Lango, R; Slominska, EM; Smolenski, RT; Suzuki, K; Yacoub, MH; Yuen, AH1
Berge-Lefranc, JL; Berland, Y; Carrega, L; Charavil, A; Dussol, B; Fenouillet, E; Gerolami, V; Giaime, P; Guieu, R; Mercier, L; Ruf, J; Saadjian, A1
Hindnavis, V; Tang, WH1
Chan, TO; Feldman, AM; Funakoshi, H; Good, JC; Herrmann, DE; Higuchi, Y; Jackson, EK; Koch, WJ; Lee, LL; Tang, Z; Zacharia, LC; Zhang, J1
Joseph, J; Rajaram, V1
Hisatome, I1
Asakura, M; Asanuma, H; Fujita, M; Furukawa, H; Isomura, T; Kim, J; Kitakaze, M; Komamura, K; Liao, Y; Nakamaru, K; Tomoike, H1
Khouadja, H; Mebazaa, A; Rezlan, E; Tavares, M; Vostroknoutova, I1
Greene, EL; Liang, KV; Redfield, MM; Williams, AW1
Miracle, C; Thomson, S; Vallon, V1
Böhm, M; De Luca, L; Dickstein, K; El-Banayosy, A; Filippatos, G; Gheorghiade, M; Mebazaa, A; Nieminen, M; Parissis, JT; Rhodes, A; Voors, AA; Zannad, F1
Chiu, J; Fonarow, GC; Hage, A; Hamilton, MA; Maclellan, WR; Middlekauff, HR; Moriguchi, J; Patel, J1
Bache, RJ; Chen, Y; Fassett, J; Hu, X; Li, Y; Lu, Z; Schnermann, J; Xu, X; Zhu, G1
Advenier, C1
James, T; Parmley, WW; Sievers, R; Wikman-Coffelt, J1
Frankis, MB; Grossman, SJ; Newman, WH; Webb, JG1
Forman, S; Heyrich, GP; Keen, WD; Marshall, ES; Raichlen, JS; Weitz, HH1
Goodfellow, J; Henderson, AH; Jones, CJ; Lewis, MJ; Luddington, LA; Ramsey, MW1
Mahmarian, AC; Mahmarian, JJ; Marks, GF; Pratt, CM; Verani, MS1
Cohn, JN; Francis, GS; McDonald, KM; Ugurbil, K; Yoshiyama, M; Zhang, J1
Albes, JM; Haverich, A; Rohde, R1
Bishop, SP; Komamura, K; Shannon, RP; Shen, YT; Vatner, SF1
Bakker, SJ; Leunissen, KM1
Marsh, JD; Vander Heide, RS1
Arnold, JE; Suarez, WA; Van Hare, GF; Wexler, ID1
Feldman, AM; McTiernan, C; Sanders, VJ; Wagner, DR1
Nekooeian, AA; Tabrizchi, R2
Canetti, M; Cohen, G; Elkayam, U; Karaalp, IS; Mehra, A; Tummala, PP; Wani, OR1
Castaño, HH; Dec, GW; Dinsmore, RE; Fifer, MA; Mathier, MA; Miyamoto, MI; Palacios, IF; Rose, GA; Semigran, MJ1
Brown, MD; Deveci, D; Hudlicka, O; Thomas, DP1
Feldman, AM; McNamara, DM; Wagner, DR1
Hori, M; Kitakaze, M2
Hashimoto, K; Inoue, K; Lurie, KG; Shirai, T; Sugiyama, A1
Edvinsson, L; Erlinge, D; Hedner, T; Sun, XY; Zhao, XH1
Gibbons, RJ; Hart, CY; Hodge, DO; Miller, TD1
Atchison, DJ; Floras, JS; Notarius, CF; Rongen, GA1
Gottlieb, SS1
Arimura, K; Egashira, K; Ide, T; Machida, Y; Nakamura, R; Shimokawa, H; Takeshita, A; Tsutsui, H1
Maehara, K; Maruyama, Y; Niitsuma, T; Oikawa, Y; Saito, T; Saitoh, S; Tamagawa, K1
Canty, JM; Fallavollita, JA1
Belloni, FL; Hintze, TH; Wang, J1
Bristow, MR; Feldman, AM; Hershberger, RE1
Burch, M; Carter, ND; Jeffery, S; Rigby, ML; Shinebourne, EA; Smith, A; Till, JA1
Apstein, CS; Cerel, AW; Vogel, WM1
Böhm, M; Diet, F; Erdmann, E; Kemkes, B; Wankerl, M1
Vatner, SF1

Reviews

30 review(s) available for adenosine and Heart Failure

ArticleYear
Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure.
    Current heart failure reports, 2022, Volume: 19, Issue:5

    Topics: Adenosine; Cytosine; Epigenesis, Genetic; Guanosine; Heart Failure; Humans; Inosine; Ribose; RNA, Small Untranslated; Transcriptome

2022
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials.
    European heart journal. Cardiovascular pharmacotherapy, 2023, 02-02, Volume: 9, Issue:2

    Topics: Acute Coronary Syndrome; Adenosine; Atrioventricular Block; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Vasodilator Agents

2023
Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).
    American journal of physiology. Cell physiology, 2019, 12-01, Volume: 317, Issue:6

    Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Arteries; Calcinosis; Central Nervous System; Gene Expression Regulation; GPI-Linked Proteins; Heart Failure; Homeostasis; Humans; Mutation, Missense; Myocardial Infarction; Organ Specificity; Reperfusion Injury; Respiratory System

2019
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
RNA modifications in cardiovascular diseases, the potential therapeutic targets.
    Life sciences, 2021, Aug-01, Volume: 278

    Topics: Adenosine; Animals; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Epigenesis, Genetic; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy; Metabolic Syndrome; Methylation; Mice; Microcirculation; Myocardium; Regeneration; Reperfusion Injury; RNA; RNA Processing, Post-Transcriptional; RNA, Untranslated; Transcriptome

2021
Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.
    Circulation, 2018, 05-29, Volume: 137, Issue:22

    Topics: Adenosine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Child; Guidelines as Topic; Heart Diseases; Heart Failure; Humans; Hypertension, Pulmonary; Vasodilator Agents

2018
Partial Adenosine A1 Agonist in Heart Failure.
    Handbook of experimental pharmacology, 2017, Volume: 243

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles

2017
Cardiac protection during acute myocardial infarction.
    Wiener klinische Wochenschrift, 2007, Volume: 119, Issue:11-12 Supp

    Topics: Adenosine; Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Combined Modality Therapy; Heart Failure; Hospital Mortality; Humans; Myocardial Infarction; Purinergic P1 Receptor Agonists; Stents; Survival Rate; Thrombolytic Therapy

2007
Cardiorenal syndrome and heart failure.
    Current opinion in cardiology, 2010, Volume: 25, Issue:2

    Topics: Adenosine; Anemia; Chronic Disease; Diuretics; Heart Failure; Hemofiltration; Humans; Kidney Failure, Chronic; Prognosis; Renin-Angiotensin System; Risk Factors; Vasodilator Agents; Vasopressins

2010
Diuretic therapy in heart failure: current controversies and new approaches for fluid removal.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2010, Volume: 11, Issue:8

    Topics: Adenosine; Cardiovascular Diseases; Heart Failure; Hemofiltration; Hormone Antagonists; Humans; Kidney Diseases; Risk Assessment; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Vasopressins; Water-Electrolyte Balance

2010
Adenosine A1 receptor antagonists in clinical research and development.
    Kidney international, 2010, Volume: 78, Issue:5

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Clinical Trials as Topic; Diuretics; Drug Resistance; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Receptor, Adenosine A1

2010
[What is new in the medical management of acute heart failure?].
    Revue medicale suisse, 2010, Jun-09, Volume: 6, Issue:252

    Topics: Acute Disease; Adenosine; Algorithms; Cardiotonic Agents; Diuretics; Drug Therapy, Combination; Etiocholanolone; Heart Failure; Hemodiafiltration; Humans; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Prognosis; Relaxin; Risk Factors; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins

2010
Can we prevent or treat renal dysfunction in acute heart failure?
    Heart failure reviews, 2012, Volume: 17, Issue:2

    Topics: Acute Disease; Adenosine; Biomarkers; Cardiotonic Agents; Diuretics; Dopamine; Heart Failure; Humans; Kidney; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Prognosis; Vasodilator Agents; Vasopressins

2012
Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials.
    Atherosclerosis, 2012, Volume: 222, Issue:1

    Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Coronary Angiography; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Treatment Outcome

2012
Ticagrelor in ST-elevation myocardial infarction.
    Current vascular pharmacology, 2012, Volume: 10, Issue:4

    Topics: Adenosine; Animals; Arrhythmias, Cardiac; Evidence-Based Medicine; Heart Failure; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor

2012
Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Therapeutic advances in cardiovascular disease, 2012, Volume: 6, Issue:3

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Creatine Kinase, MB Form; Electrocardiography; Heart Failure; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Randomized Controlled Trials as Topic; Stents; Stroke Volume; Vasodilator Agents

2012
[The no-reflow phenomenon and its clinical significance].
    Kardiologiia, 2002, Volume: 42, Issue:5

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Atherectomy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Heart Failure; Hospital Mortality; Humans; Microvascular Angina; Myocardial Infarction; Nicorandil; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Stents; Vasodilator Agents; Verapamil

2002
Adenosine A1 receptor antagonists and the kidney.
    Current opinion in nephrology and hypertension, 2003, Volume: 12, Issue:5

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Heart Failure; Humans; Kidney; Receptor, Adenosine A1; Renal Insufficiency; Reperfusion Injury

2003
A rational approach for the treatment of acute heart failure: current strategies and future options.
    Current opinion in cardiology, 2004, Volume: 19, Issue:3

    Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins

2004
[Hemodialysis-related hypotension].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6

    Topics: Adenosine; Antihypertensive Agents; Arteriosclerosis; Autonomic Nervous System Diseases; Body Weight; Heart Failure; Humans; Hypotension; Hypotension, Orthostatic; Kidney Failure, Chronic; Nitric Oxide; Renal Dialysis

2004
Current and novel pharmacological approaches to renal insufficiency in heart failure.
    Minerva cardioangiologica, 2006, Volume: 54, Issue:6

    Topics: Adenosine; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Agents; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Natriuretic Agents; Natriuretic Peptide, Brain; Natriuretic Peptides; Neurotransmitter Agents; Prognosis; Renal Insufficiency; Treatment Outcome; Vasodilator Agents; Vasopressins

2006
Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential.
    Current heart failure reports, 2007, Volume: 4, Issue:3

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Diuresis; Heart Failure; Humans; Prognosis; Renal Circulation; Renal Insufficiency; Vasodilator Agents

2007
New pharmacologic therapies for acute heart failure.
    Critical care medicine, 2008, Volume: 36, Issue:1 Suppl

    Topics: Acute Disease; Adenosine; Adenosine Triphosphatases; Antidiuretic Hormone Receptor Antagonists; Cardiac Myosins; Cardiotonic Agents; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Natriuretic Peptides; Pyridazines; Simendan

2008
Acute decompensated heart failure and the cardiorenal syndrome.
    Critical care medicine, 2008, Volume: 36, Issue:1 Suppl

    Topics: Acute Disease; Adenosine; Cardiotonic Agents; Dopamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Renal Insufficiency; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Ultrafiltration; Vasopressins

2008
Adenosine and kidney function: potential implications in patients with heart failure.
    European journal of heart failure, 2008, Volume: 10, Issue:2

    Topics: Adenosine; Animals; Heart Failure; Humans; Kidney; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Receptors, Purinergic P1; Reperfusion Injury; Vasoconstriction; Vasopressins; Xanthines

2008
Overview of emerging pharmacologic agents for acute heart failure syndromes.
    European journal of heart failure, 2008, Volume: 10, Issue:2

    Topics: Adenosine; Cardiovascular Agents; Endothelin-1; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Hydrazones; Natriuretic Peptide, Brain; Perhexiline; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Sodium-Potassium-Exchanging ATPase; Syndrome; Vasodilator Agents

2008
[Theophylline: mechanism of action, pharmacokinetics and metabolism].
    Allergologia et immunopathologia, 1981, Volume: Suppl 9

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adult; Calcium; Child; Cyclic AMP; Drug Interactions; Heart Failure; Humans; Kinetics; Liver Diseases; Muscle Contraction; Muscle, Smooth; Phosphodiesterase Inhibitors; Respiration Disorders; Theophylline

1981
It is time to ask what adenosine can do for cardioprotection.
    Heart and vessels, 1998, Volume: 13, Issue:5

    Topics: 5'-Nucleotidase; Adenosine; Cardiovascular Agents; Collateral Circulation; Heart Failure; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion Injury; Protein Kinase C

1998
Adenosine therapy: a new approach to chronic heart failure.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:11

    Topics: Adenosine; Animals; Cardiac Output, Low; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1

2000
Renal effects of adenosine A1-receptor antagonists in congestive heart failure.
    Drugs, 2001, Volume: 61, Issue:10

    Topics: Adenosine; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Prognosis; Purinergic P1 Receptor Antagonists; Sodium

2001

Trials

8 trial(s) available for adenosine and Heart Failure

ArticleYear
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.
    American heart journal, 2023, Volume: 257

    Topics: Adenosine; Heart Failure; Humans; Prospective Studies; Registries; Stroke Volume; Takotsubo Cardiomyopathy; Treatment Outcome; Ventricular Function, Left

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: t
    JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:6

    Topics: Adenosine; Aged; Coronary Angiography; Coronary Circulation; Drug Administration Schedule; Electrocardiography; Female; Heart Failure; Hospitalization; Humans; Italy; Male; Microcirculation; Middle Aged; Myocardial Infarction; Nitroprusside; Percutaneous Coronary Intervention; Recurrence; Suction; Thrombectomy; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents

2013
Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failure.
    European journal of heart failure, 2011, Volume: 13, Issue:5

    Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Brachial Artery; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Norepinephrine; Reflex; Regional Blood Flow; Sympathetic Nervous System; Tetrazoles; Vasodilator Agents

2011
Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session.
    Journal of the American College of Cardiology, 2002, Jul-03, Volume: 40, Issue:1

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Antihypertensive Agents; Atherectomy, Coronary; Atrial Fibrillation; Azithromycin; Chlamydophila Infections; Coronary Disease; Defibrillators, Implantable; Double-Blind Method; Eplerenone; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Myocardial Reperfusion; Pyridines; Radiology, Interventional; Spironolactone; Stents; Thiazepines; Thrombolytic Therapy

2002
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
    Journal of the American College of Cardiology, 2005, Jun-07, Volume: 45, Issue:11

    Topics: Adenosine; Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Thrombolytic Therapy; Vasodilator Agents

2005
Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4

    Topics: Adenosine; Adult; Aminophylline; Blood Pressure; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Hand Strength; Heart Failure; Heart Rate; Humans; Indomethacin; Infusions, Intravenous; Male; Mechanoreceptors; Mechanotransduction, Cellular; Middle Aged; Muscle Contraction; Muscle, Skeletal; Peroneal Nerve; Prostaglandin-Endoperoxide Synthases; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Reflex; Research Design; Sympathetic Nervous System; Time Factors

2008
Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:3

    Topics: Adenosine; Blood Pressure; Caffeine; Exercise Test; Female; Hand Strength; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Ischemia; Isometric Contraction; Isotonic Contraction; Male; Middle Aged; Muscle, Skeletal; Purinergic P1 Receptor Antagonists; Reflex; Sympathetic Nervous System

2001

Other Studies

75 other study(ies) available for adenosine and Heart Failure

ArticleYear
Coronary microvascular dysfunction and findings of heart failure with preserved ejection fraction in patients with microvascular angina.
    Minerva medica, 2022, Volume: 113, Issue:5

    Topics: Adenosine; Heart Failure; Humans; Myocardial Ischemia; Stroke Volume

2022
Regulation of N6-Methyladenosine after Myocardial Infarction.
    Cells, 2022, 07-22, Volume: 11, Issue:15

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Female; Heart Failure; Humans; Myocardial Infarction; RNA, Messenger; Ventricular Function, Left

2022
ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
    Circulation research, 2022, 09-16, Volume: 131, Issue:7

    Topics: Adenosine; Adenosine Deaminase; Animals; Heart Failure; Inosine; Interferon Regulatory Factor-7; Interferon-Induced Helicase, IFIH1; Interferons; Mice; Mice, Mutant Strains; NF-kappa B; RNA

2022
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I
    Life sciences, 2020, Jan-01, Volume: 240

    Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Bee Venoms; Biological Clocks; Chronic Disease; Dogs; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart Failure; Heart Rate; In Vitro Techniques; Male; Patch-Clamp Techniques; Potassium Channel Blockers; Receptor, Adenosine A1; Sinoatrial Node; Xanthines

2020
High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:7

    Topics: Adenosine; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Tachycardia, Paroxysmal; Tachycardia, Supraventricular

2020
Remodeling of the m
    Journal of molecular and cellular cardiology, 2021, Volume: 151

    Topics: Adenosine; Animals; Animals, Newborn; Base Sequence; Biocatalysis; Cardiomegaly; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Rats; RNA, Messenger; Stress, Physiological; Transcription, Genetic

2021
Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    BMC cardiovascular disorders, 2017, 04-08, Volume: 17, Issue:1

    Topics: Adenosine; Aged; Aged, 80 and over; Cardiomyopathies; Contrast Media; Coronary Angiography; Diagnosis, Differential; Female; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Risk Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left

2017
Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
    Circulation. Heart failure, 2017, Volume: 10, Issue:4

    Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Aorta; Collagen; Constriction; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation; Interleukin-3; Male; Mice; Mice, Knockout; Signal Transduction; T-Lymphocytes

2017
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2018, 01-11, Volume: 20, Issue:1

    Topics: Adenosine; Adult; Aged; Aged, 80 and over; Cause of Death; Clinical Trials as Topic; Contrast Media; Coronary Circulation; Echocardiography; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Prognosis; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left

2018
Cutting Edge Science and Medicine of Adenosine in Patients With Heart Failure.
    Circulation journal : official journal of the Japanese Circulation Society, 2018, 04-25, Volume: 82, Issue:5

    Topics: Adenosine; Dilatation; Heart Diseases; Heart Failure; Humans; Ventricular Dysfunction, Left

2018
Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock.
    Critical care medicine, 2018, Volume: 46, Issue:9

    Topics: Adenosine; Aged; Blood Pressure; Female; Heart Failure; Humans; Male; Myocardial Contraction; Myocardial Infarction; Prospective Studies; Receptor, Adenosine A2A; Shock, Cardiogenic; Vasodilation

2018
FTO-Dependent N
    Circulation, 2019, 01-22, Volume: 139, Issue:4

    Topics: Adenosine; Adult; Aged; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Calcium Signaling; Case-Control Studies; Cell Line; Cell Proliferation; Demethylation; Disease Models, Animal; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Myocardial Infarction; Myocytes, Cardiac; Rats, Sprague-Dawley; Regeneration; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Sus scrofa; Ventricular Function, Left; Ventricular Remodeling

2019
Prognostic value of a new semiquantitative score system for adenosine stress myocardial perfusion by CMR.
    European radiology, 2019, Volume: 29, Issue:5

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Arrhythmias, Cardiac; Coronary Artery Disease; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis

2019
The Effect of Cardiac Preservation Solutions on Heart Transplant Survival.
    The Journal of surgical research, 2019, Volume: 242

    Topics: Adenosine; Adolescent; Adult; Aged; Allografts; Allopurinol; Cardioplegic Solutions; Disaccharides; Electrolytes; Female; Follow-Up Studies; Glucose; Glutamates; Glutathione; Graft Rejection; Graft Survival; Heart; Heart Failure; Heart Transplantation; Histidine; Humans; Insulin; Male; Mannitol; Middle Aged; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Retrospective Studies; Saline Solution; Survival Analysis; Treatment Outcome; Young Adult

2019
Acute intravenous infusion of an adenosine regulating agent improves left ventricular function in dogs with advanced heart failure.
    Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6

    Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Deoxyribonucleosides; Dogs; Heart Failure; Hemodynamics; Infusions, Intravenous; Purinergic P1 Receptor Antagonists; Theophylline; Ventricular Function, Left

2013
[A high-volume single center experience of no-reflow post-percutaneous coronary intervention].
    Giornale italiano di cardiologia (2006), 2014, Volume: 15, Issue:2

    Topics: Adenosine; Aged; Female; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Nitroprusside; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Retrospective Studies; Ventricular Function, Left

2014
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
    Circulation, 2014, Jul-22, Volume: 130, Issue:4

    Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Dogs; Dose-Response Relationship, Drug; Fibrosis; Heart Conduction System; Heart Failure; Receptor, Adenosine A1; Sinoatrial Node; Tachycardia; Theophylline; Up-Regulation; Voltage-Sensitive Dye Imaging; Xanthines

2014
[Multination clinical trials: what is the relevance and what are the lessons from across-country differences?].
    Giornale italiano di cardiologia (2006), 2014, Volume: 15, Issue:4

    Topics: Acute Coronary Syndrome; Adenosine; Americas; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Ethnicity; Europe; Female; Georgia (Republic); Heart Failure; Humans; Internationality; Male; Metoprolol; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Russia; Sample Size; Spironolactone; Ticagrelor; Ticlopidine; Tolvaptan

2014
Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion.
    Journal of translational medicine, 2014, May-21, Volume: 12

    Topics: Adenosine; Animals; Glycogen; Heart Failure; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Myocardium; Rats; Rats, Wistar; Reperfusion Injury

2014
Early opening of sarcolemmal ATP-sensitive potassium channels is not a key step in PKC-mediated cardioprotection.
    Journal of molecular and cellular cardiology, 2015, Volume: 79

    Topics: Action Potentials; Adenosine; Animals; Cardiotonic Agents; Cell Separation; Diazoxide; Enzyme Activation; Heart Failure; Ion Channel Gating; Ischemic Preconditioning, Myocardial; Isoenzymes; KATP Channels; Male; Myocardial Contraction; Myocardial Reperfusion; Myocytes, Cardiac; Phenotype; Pinacidil; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Rats, Wistar; Sarcolemma; Tetradecanoylphorbol Acetate; Time Factors

2015
Patients with reduced heart rate response to adenosine infusion have low myocardial flow reserve in (13)N-ammonia PET studies.
    The international journal of cardiovascular imaging, 2015, Volume: 31, Issue:5

    Topics: Adenosine; Aged; Ammonia; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Female; Fractional Flow Reserve, Myocardial; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Time Factors

2015
Platelet inhibition with ticagrelor for left ventricular assist device thrombosis.
    Circulation. Heart failure, 2015, Volume: 8, Issue:3

    Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Heart Failure; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Thrombosis; Ticagrelor; Treatment Outcome; Ventricular Function, Left

2015
High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:10

    Topics: Adenosine; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Agents; Coronary Circulation; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Stress, Psychological; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left

2015
Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure.
    Journal of cardiac failure, 2008, Volume: 14, Issue:5

    Topics: 5'-Nucleotidase; Adenosine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Female; Gene Expression; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Severity of Illness Index; Stroke Volume

2008
Peripheral plasma adenosine release in patients with chronic heart failure.
    Heart (British Cardiac Society), 2009, Volume: 95, Issue:8

    Topics: Adenosine; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Coronary Sinus; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Serum Albumin; Troponin I

2009
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
    Pediatric emergency care, 2010, Volume: 26, Issue:2

    Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Failure; Heart Neoplasms; Heart Rate; Humans; Hypotension; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Retrospective Studies; Rhabdomyoma; Shock, Cardiogenic; Tachycardia, Supraventricular; Thyrotropin; Treatment Outcome

2010
Playing hide and seek with adenosine receptors.
    Clinical and translational science, 2008, Volume: 1, Issue:2

    Topics: Adenosine; Animals; Heart Failure; Heart Function Tests; Humans; Mice; Mice, Transgenic; Receptors, Purinergic P1

2008
Continuous perfusion of donor hearts with oxygenated blood cardioplegia improves graft function.
    Transplant international : official journal of the European Society for Organ Transplantation, 2010, Volume: 23, Issue:11

    Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Cardiac Output; Glutathione; Heart Arrest, Induced; Heart Failure; Heart Transplantation; Insulin; Ischemia; Male; Malondialdehyde; Organ Preservation; Organ Preservation Solutions; Perfusion; Raffinose; Swine; Swine, Miniature; Time Factors

2010
The cardiorenal syndrome in heart failure: an evolving paradigm.
    The American journal of the medical sciences, 2010, Volume: 340, Issue:1

    Topics: Adenosine; Heart Failure; Humans; Kidney Diseases; Natriuretic Agents; Ultrafiltration; Vasopressins

2010
Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2011, Volume: 30, Issue:9

    Topics: Adenosine; Adult; Allopurinol; Cohort Studies; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Heart Failure; Heart Transplantation; Histidine; Humans; Insulin; Kaplan-Meier Estimate; Male; Mannitol; Middle Aged; Multivariate Analysis; Organ Preservation; Organ Preservation Solutions; Raffinose; Retrospective Studies; Survival Rate; Treatment Outcome; United States

2011
Effectiveness of nuclear scan strategy in low-risk chest pain patients: novel insights from the real world.
    Nuclear medicine communications, 2011, Volume: 32, Issue:12

    Topics: Adenosine; Angina, Unstable; Chest Pain; Coronary Artery Disease; Coronary Stenosis; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Prognosis; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2011
A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:4

    Topics: Adenosine; Adult; Allopurinol; Biopsy; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Graft Rejection; Heart Failure; Heart Transplantation; Histidine; Humans; Incidence; Insulin; Male; Mannitol; Middle Aged; Multivariate Analysis; Myocardial Reperfusion Injury; Myocardium; Necrosis; Organ Preservation; Organ Preservation Solutions; Primary Graft Dysfunction; Raffinose; Retrospective Studies; Survival Rate; Transplantation, Homologous

2012
Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency.
    Bulletin of experimental biology and medicine, 2011, Volume: 150, Issue:5

    Topics: Acetyldigoxins; Adenosine; Adenosine Triphosphate; Animals; Apoptosis; Cardiotonic Agents; Constriction, Pathologic; Female; Heart; Heart Failure; Heart Ventricles; Hydrazones; Male; Milrinone; Myocardium; Myocytes, Cardiac; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridazines; Rabbits; Reperfusion; Simendan; Ventricular Function

2011
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
    JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:6

    Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Coronary Vessels; Female; Heart Failure; Hospitalization; Humans; Laser-Doppler Flowmetry; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Nitroglycerin; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Stroke; United States; Vasodilator Agents

2012
Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study.
    Radiology, 2003, Volume: 226, Issue:3

    Topics: Adenosine; Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Electrocardiography; Feasibility Studies; Female; Gadolinium DTPA; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Troponin T

2003
A patient with chaotic atrial tachycardia.
    Pediatric emergency care, 2003, Volume: 19, Issue:2

    Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality Therapy; Diagnosis, Differential; Dyspnea; Electroencephalography; Emergencies; Female; Fluid Therapy; Furosemide; Heart Failure; Heart Septal Defects, Atrial; Humans; Infant; Procainamide; Recurrence; Tachycardia; Tachycardia, Ectopic Atrial

2003
[Adenosine-tri-phosphatase activity of the heart in myocardial insufficiency].
    Minerva medica, 1952, Jun-11, Volume: 43, Issue:47

    Topics: Adenosine; Heart Failure; Humans; Myocardium; Phosphoric Monoester Hydrolases

1952
Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
    Cardiovascular research, 2003, Sep-01, Volume: 59, Issue:3

    Topics: Adenosine; Adult; AMP Deaminase; Bacterial Proteins; Exercise Test; Female; Heart Failure; Heterozygote; Homozygote; Humans; Male; Mutation; Myocardium; N-Acetylmuramoyl-L-alanine Amidase; Polymorphism, Single-Stranded Conformational; Protein Isoforms

2003
Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation.
    Journal of cardiac failure, 2005, Volume: 11, Issue:1

    Topics: Adenosine; Blotting, Western; Female; Heart Failure; Humans; Lipopolysaccharides; Male; Middle Aged; Neutrophils; Phenethylamines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; Triazines; Triazoles; Tumor Necrosis Factor-alpha; Up-Regulation

2005
Prevention of adriamycin induced heart failure by an increase in endogenous adenosine production.
    Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:4

    Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Doxorubicin; Echocardiography; Heart Failure; Nucleotides; Rats; Rats, Sprague-Dawley; Time Factors

2005
Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:3

    Topics: Adenosine; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; Chromatography; Creatinine; Cross-Sectional Studies; Female; Freeze Drying; Gene Expression; Heart Failure; Humans; Inflammation; Kidney Failure, Chronic; Leukocytes, Mononuclear; Male; Middle Aged; Prognosis; Receptor, Adenosine A2A; Renal Dialysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left

2007
A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction.
    Circulation, 2007, May-01, Volume: 115, Issue:17

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Disease Models, Animal; Female; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Myocardium; Receptor, Adenosine A1; Receptor, Adenosine A2A; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation; Ventricular Dysfunction, Left

2007
Adenosine and cardioprotection in chronic heart failure: genes and protein expression.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:9

    Topics: Adenosine; Adult; Aged; Chronic Disease; Female; Gene Expression; Heart Failure; Humans; Male; Middle Aged; Myocardium; Receptors, Purinergic P1

2007
Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:9

    Topics: Adenosine; Adult; Aged; Chronic Disease; Dipyridamole; Female; Gene Expression; Gene Expression Profiling; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oligonucleotide Array Sequence Analysis; Phosphodiesterase Inhibitors; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction

2007
Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6

    Topics: 5'-Nucleotidase; Adenosine; Animals; Blood Pressure; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Fibrosis; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases; Ventricular Dysfunction, Left

2008
Energy levels at systole vs. diastole in normal hamster hearts vs. myopathic hamster hearts.
    Circulation research, 1983, Volume: 53, Issue:6

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cricetinae; Energy Metabolism; Heart Failure; Lactates; Lactic Acid; Mesocricetus; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphates; Phosphocreatine; Systole

1983
Increased myocardial adenosine release in heart failure.
    Journal of molecular and cellular cardiology, 1984, Volume: 16, Issue:6

    Topics: Adenosine; Animals; Dogs; Heart Failure; Heart Ventricles; Isoproterenol; Myocardial Contraction; Myocardium

1984
Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular surgery.
    The American journal of cardiology, 1995, Oct-15, Volume: 76, Issue:11

    Topics: Adenosine; Aged; Aged, 80 and over; Chi-Square Distribution; Female; Heart; Heart Failure; Humans; Intraoperative Complications; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Peripheral Vascular Diseases; Postoperative Complications; Predictive Value of Tests; Preoperative Care; Pulmonary Edema; Radionuclide Imaging; Regression Analysis; Risk Factors; Sensitivity and Specificity; Vasodilator Agents

1995
Endothelial control of arterial distensibility is impaired in chronic heart failure.
    Circulation, 1995, Dec-01, Volume: 92, Issue:11

    Topics: Acetylcholine; Adenosine; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, Dilated; Case-Control Studies; Female; Heart Failure; Humans; Iliac Artery; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Ultrasonography; Vascular Resistance; Vasodilation; Vasodilator Agents

1995
Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:6

    Topics: Adenosine; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Death, Sudden, Cardiac; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed

1995
Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction.
    Journal of the American College of Cardiology, 1994, Mar-01, Volume: 23, Issue:3

    Topics: Adenosine; Adenosine Triphosphate; Animals; Coronary Circulation; Dogs; Heart Failure; Hypertrophy, Left Ventricular; Magnetic Resonance Spectroscopy; Myocardial Infarction; Myocardium; Phosphocreatine; Time Factors; Ventricular Function, Left

1994
Protection of the right ventricular myocardium during acute right heart failure from pulmonary hypertension.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1994, Volume: 26, Issue:1

    Topics: Acute Disease; Adenosine; Allopurinol; Animals; Cardioplegic Solutions; Disease Models, Animal; Embolectomy; Evaluation Studies as Topic; Extracorporeal Circulation; Glucose; Glutathione; Heart Arrest, Induced; Heart Failure; Hypertension, Pulmonary; Insulin; Male; Myocardial Reperfusion Injury; Organ Preservation Solutions; Pulmonary Embolism; Raffinose; Rats; Rats, Inbred Lew; Tromethamine; Ventricular Function, Right

1994
Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure.
    The American journal of physiology, 1993, Volume: 265, Issue:3 Pt 2

    Topics: Adenosine; Animals; Blood Pressure; Blood Vessels; Cardiac Pacing, Artificial; Coronary Circulation; Diastole; Dogs; Endocardium; Female; Heart Failure; Hemodynamics; Male; Microcirculation; Reference Values; Ventricular Function, Left

1993
Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilatation in cardiovascular beriberi.
    Medical hypotheses, 1995, Volume: 45, Issue:3

    Topics: Acetyl Coenzyme A; Acidosis, Lactic; Adenosine; Adenosine Triphosphate; Beriberi; Ethanol; Heart Failure; Humans; Ketoglutarate Dehydrogenase Complex; Models, Biological; Pyruvate Dehydrogenase Complex Deficiency Disease; Thiamine; Vasodilation

1995
Through the looking glass: a positive inotropic drug and ischemic preconditioning.
    Circulation, 1997, Apr-15, Volume: 95, Issue:8

    Topics: 5'-Nucleotidase; Adenosine; Animals; Cardiotonic Agents; Dogs; Drug Approval; Enzyme Activation; Heart Failure; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardium; Neutropenia; Protein Kinase C; Pyrazines; Quinolines; Second Messenger Systems

1997
Atrial flutter: an uncommon pediatric manifestation of hyperthyroidism.
    Pediatrics, 1997, Volume: 100, Issue:2

    Topics: Adenosine; Atrial Flutter; Child, Preschool; Electrocardiography; Heart Failure; Humans; Hyperthyroidism

1997
Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart.
    Circulation, 1998, Feb-17, Volume: 97, Issue:6

    Topics: Adenosine; Adult; Analysis of Variance; Cardiovascular Agents; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Heart Failure; Humans; In Vitro Techniques; Lipopolysaccharides; Male; Middle Aged; Tubercidin; Tumor Necrosis Factor-alpha

1998
Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    British journal of pharmacology, 1998, Volume: 123, Issue:8

    Topics: Acute Disease; Adenosine; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Male; Microspheres; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Vascular Resistance; Ventricular Function, Left

1998
Renal circulatory effects of adenosine in patients with chronic heart failure.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:1

    Topics: Adenosine; Adult; Blood Flow Velocity; Chronic Disease; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Renal Circulation; Vascular Resistance; Ventricular Dysfunction, Left

1998
Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:1

    Topics: Acetylcholine; Acute Disease; Adenosine; Adolescent; Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Coronary Circulation; Endothelium, Vascular; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Stroke Volume; Systole; Vasodilator Agents; Ventricular Function, Left

1998
Alterations in small arterioles precede changes in limb skeletal muscle after myocardial infarction.
    The American journal of physiology, 1998, Volume: 275, Issue:3

    Topics: Acetylcholine; Adenosine; Animals; Arterioles; Female; Heart Failure; Hemodynamics; Muscle, Skeletal; Myocardial Infarction; Norepinephrine; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Ventricular Function, Left

1998
Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    British journal of pharmacology, 1998, Volume: 125, Issue:4

    Topics: Adenosine; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiac Output; Coronary Disease; Heart Failure; Heart Rate; Hemodynamics; Ligation; Male; Organ Size; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Time Factors; Vascular Resistance

1998
AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
    Circulation, 1999, Mar-23, Volume: 99, Issue:11

    Topics: Adenosine; Adenosine Monophosphate; Alleles; AMP Deaminase; Cardiomyopathy, Dilated; Disease Progression; Energy Metabolism; Genetic Predisposition to Disease; Genotype; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1

1999
Measurement of adenylate cyclase activity in the right ventricular endomyocardial biopsy samples from patients with chronic congestive heart failure.
    Journal of clinical laboratory analysis, 2000, Volume: 14, Issue:2

    Topics: Adenosine; Adenylyl Cyclases; Adult; Biopsy; Cell Membrane; Chronic Disease; Colforsin; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Norepinephrine; Spectrometry, Fluorescence

2000
Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats.
    Blood pressure, 2000, Volume: 9, Issue:2-3

    Topics: Adenosine; Adenosine Triphosphate; Animals; Blood Pressure; Cardiovascular System; Decerebrate State; Down-Regulation; Electric Stimulation; Ganglia; Heart Failure; Heart Rate; Male; Myocardial Infarction; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2

2000
Specificity of the stress electrocardiogram during adenosine myocardial perfusion imaging in patients taking digoxin.
    American heart journal, 2000, Volume: 140, Issue:6

    Topics: Adenosine; Aged; Atrial Fibrillation; Cardiotonic Agents; Coronary Disease; Diagnosis, Differential; Digoxin; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Radionuclide Ventriculography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Vasodilator Agents

2000
Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:6

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Adenosine; Animals; Coronary Circulation; Dogs; Echocardiography; Endothelium, Vascular; Enzyme Inhibitors; Heart Failure; Hyperemia; Immunohistochemistry; Indicators and Reagents; Lipid Peroxidation; Myocardium; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pacemaker, Artificial; Reactive Oxygen Species; Tachycardia; Vasodilator Agents

2001
Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:1

    Topics: Acetylcholine; Adenosine; Animals; Carbon Dioxide; Coronary Circulation; Diastole; Dogs; Endothelium, Vascular; Fasting; Female; Heart Failure; Heart Rate; Hemodynamics; Male; Nitric Oxide; Nitroarginine; Oxygen; Partial Pressure; Perfusion; Regional Blood Flow

2002
Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:4

    Topics: Adenosine; Animals; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Heart; Heart Failure; Hemodynamics; Myocardial Ischemia; Perfusion; Reference Values; Swine; Systole; Time Factors; Vasoconstriction; Ventricular Dysfunction, Left; Ventricular Function, Left

2002
Adenosine causes bradycardia in pacing-induced cardiac failure.
    Circulation, 1992, Volume: 85, Issue:3

    Topics: Adenosine; Animals; Cardiac Pacing, Artificial; Cardiomegaly; Depression, Chemical; Dogs; Heart; Heart Failure; Heart Rate; Parasympathetic Nervous System; Pressoreceptors; Sinoatrial Node

1992
A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.
    Circulation, 1991, Volume: 83, Issue:4

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adult; Female; GTP-Binding Proteins; Heart Failure; Humans; In Vitro Techniques; Male; Myocardium; Phenylisopropyladenosine; Receptors, Purinergic; Vasodilator Agents

1991
Plasma concentration of atrial natriuretic peptide in spontaneous atrioventricular re-entrant tachycardias of childhood.
    British heart journal, 1990, Volume: 64, Issue:5

    Topics: Adenosine; Age Factors; Atrial Natriuretic Factor; Child, Preschool; Heart Failure; Heart Rate; Humans; Infant; Infant, Newborn; Tachycardia, Atrioventricular Nodal Reentry

1990
Post-ischemic cardiac chamber stiffness and coronary vasomotion: the role of edema and effects of dextran.
    Journal of molecular and cellular cardiology, 1986, Volume: 18, Issue:12

    Topics: Adenosine; Animals; Blood Pressure; Coronary Disease; Dextrans; Edema, Cardiac; Elasticity; Heart Failure; Hypoxia; In Vitro Techniques; Osmotic Pressure; Perfusion; Rabbits; Vascular Resistance; Vasodilation

1986
Inotropic response to DPI 201-106 in the failing human heart.
    British journal of pharmacology, 1989, Volume: 98, Issue:1

    Topics: Adenosine; Adult; Aged; Aging; Calcium; Carbachol; Electric Stimulation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Papillary Muscles; Piperazines; Receptors, Adrenergic, beta

1989
Reduced subendocardial myocardial perfusion as one mechanism for congestive heart failure.
    The American journal of cardiology, 1988, Sep-09, Volume: 62, Issue:8

    Topics: Adenosine; Animals; Cardiomegaly; Coronary Circulation; Dogs; Endocardium; Heart Failure; Heart Rate; Hyperemia; Pericardium; Physical Exertion; Vascular Resistance

1988